Global Histone Deacetylase (HDAC) Inhibitors Market Growth 2025-2031

Global Histone Deacetylase (HDAC) Inhibitors Market Growth 2025-2031

The global Histone Deacetylase (HDAC) Inhibitors market size is predicted to grow from US$ 780 million in 2025 to US$ 1314 million in 2031; it is expected to grow at a CAGR of 9.1% from 2025 to 2031.

United States market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Histone Deacetylase (HDAC) Inhibitors players cover 4SC, Acetylon Pharmaceuticals, Celleron Therapeutics, Chipscreen Biosciences, Chroma Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Histone Deacetylase (HDAC) Inhibitors Industry Forecast” looks at past sales and reviews total world Histone Deacetylase (HDAC) Inhibitors sales in 2024, providing a comprehensive analysis by region and market sector of projected Histone Deacetylase (HDAC) Inhibitors sales for 2025 through 2031. With Histone Deacetylase (HDAC) Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Histone Deacetylase (HDAC) Inhibitors industry.

This Insight Report provides a comprehensive analysis of the global Histone Deacetylase (HDAC) Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Histone Deacetylase (HDAC) Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Histone Deacetylase (HDAC) Inhibitors market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Histone Deacetylase (HDAC) Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Histone Deacetylase (HDAC) Inhibitors.

This report presents a comprehensive overview, market shares, and growth opportunities of Histone Deacetylase (HDAC) Inhibitors market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Fatty Acid
Hydroxamate
Cyclic Peptide
Benzamide

Segmentation by Application:
Treatment of Malignant Tumors
Chronic Disease Treatment
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
4SC
Acetylon Pharmaceuticals
Celleron Therapeutics
Chipscreen Biosciences
Chroma Therapeutics
CrystalGenomics
Curis
MEI Pharma
Mirati Therapeutics
Novartis
Onxeo
Repligen
TetraLogic

Key Questions Addressed in this Report

What is the 10-year outlook for the global Histone Deacetylase (HDAC) Inhibitors market?

What factors are driving Histone Deacetylase (HDAC) Inhibitors market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Histone Deacetylase (HDAC) Inhibitors market opportunities vary by end market size?

How does Histone Deacetylase (HDAC) Inhibitors break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.